Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Thymoma Malignant Recurrent

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • CHU Caen, Caen, France

    Contact: Study coordinator (Simon DESHAYES, MD)
    Contact: Principal Investigator (Simon DESHAYES, MD)
  • CLCC François BACLESSE, Caen, France

    Contact: Study coordinator (Delphine LEROUGE, MD)
    Contact: Principal Investigator (Delphine LEROUGE, MD)
  • CLCC Georges François Leclerc, Dijon, France

    Contact: Study coordinator (Etienne MARTIN, MD)
    Contact: Principal Investigator (Etienne MARTIN, MD)
  • Centre Oscar Lambret, Lille, France

    Contact: Study coordinator (Florence LE TINIER, MD)
    Contact: Principal Investigator (Florence LE TINIER, MD)
  • CHU Lyon, Lyon, France

    Contact: Study coordinator (Thomas PIERRET, MD)
    Contact: Principal Investigator (Thomas PIERRET, MD)
  • AP-HM Hôpital Nord, Marseille, France

    Contact: Study coordinator (Pascal THOMAS, Pr)
    Contact: Principal Investigator (Pascal THOMAS, Pr)
  • Institut du Cancer de Montpellier, Montpellier, France

    Contact: Study coordinator (Xavier QUANTIN, Pr)
    Contact: Principal Investigator (Xavier QUANTIN, Pr)
  • Antoine LACASSAGNE, Nice, France

    Contact: Study coordinator (Jérôme DOYEN, MD)
    Contact: Principal Investigator (Jérôme DOYEN, MD)
  • Institut Curie, Paris, France

    Contact: Study coordinator (Nicolas GIRARD, PR) · nicolas.girard2@curie.fr
    Contact: Principal Investigator (Nicolas GIRARD, PR)
  • Hôpital Européen Georges Pompidou, Paris, France

    Contact: Study coordinator (Aurélia ALATI, MD)
    Contact: Principal Investigator (Aurélia ALATI, MD)
  • Hôpital Bichat AP-HP, Paris, France

    Contact: Study coordinator (Valérie GOUNANT, Pr)
    Contact: Principal Investigator (Valérie GOUNANT, Pr)
  • CHU Haut Lévêque, Pessac, France

    Contact: Study coordinator (POUYPOUDAT, MD)
    Contact: Principal Investigator (Claudia POUYPOUDAT, MD)
  • CHU Rennes Hôpital Sud, Rennes, France

    Contact: Study coordinator (Charles RICORDEL, MD)
    Contact: Principal Investigator (Charles RICORDEL, MD)
  • CHU Rouen, Rouen, France

  • CLCC Henri Becquerel, Rouen, France

    Contact: Study coordinator (Sébastien THUREAU, MD)
    Contact: Principal Investigator (Sébastien THUREAU, MD)
  • Institut de Cancérologie de l'Ouest, Saint-Herblain, France

    Contact: Study coordinator (François THILLAYS, MD)
    Contact: Principal Investigator (François THILLAYS, Pr)
  • CHU Strasbourg, Strasbourg, France

    Contact: Study coordinator (Pierre-Emmanuel FALCOZ, Pr)
    Contact: Principal Investigator (Pierre-Emmanuel FALCOZ, Pr)
  • Institut Claudius Regaud, Toulouse, France

    Contact: Study coordinator (Jonathan KHALIFA, MD)
    Contact: Principal Investigator (Jonathan KHALIFA, MD)
  • CHRU Tours, Tours, France

    Contact: Study coordinator (Eric PICHON, MD)
    Contact: Principal Investigator (Eric PICHON, MD)
  • Institut de Cancérologie de Lorraine Nancy, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (Mathilde CUENIN, MD)
    Contact: Principal Investigator (Mathilde CUENIN, MD)
  • Gustave Roussy, Villejuif, France

    Contact: Study coordinator (Angela BOTTICELLA, MD)
    Contact: Principal Investigator (Angela BOTTICELLA, MD)